The 3D cell culture market has been on a strong and sustained growth trajectory, driven primarily by the pharmaceutical and biotechnology industries. Now, a regulatory shift is poised to further amplify that momentum. The FDA Modernization Acts 2.0 and 3.0 have fundamentally rewritten the rules of preclinical drug development, and 3D cell culture products sit […]